TrialCirculation2022

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.

Gerasimos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.